Checkpoint Surgical

Advancing Surgical Nerve Care Through Innovative Peripheral Nerve Technologies

Checkpoint Surgical is a medical technology company focused on peripheral nerve surgery, nerve protection, nerve repair, and intraoperative neurostimulation. The company develops and commercializes surgical technologies that help surgeons identify, protect, assess, and repair nerves during complex procedures across multiple surgical specialties. Founded in 2009 and headquartered in Cleveland, Checkpoint Surgical serves healthcare providers across the United States and international markets.

Company Overview

Checkpoint Surgical develops technologies designed to improve outcomes in peripheral nerve surgery by providing surgeons with:

• Intraoperative nerve stimulation
• Nerve identification and protection tools
• Nerve repair and regeneration technologies
• Biomaterial-based surgical barriers
• Precision nerve cutting and preparation systems

The company focuses on improving functional recovery, reducing surgical variability, and supporting nerve regeneration across reconstructive, orthopedic, plastic, neurosurgical, and head & neck procedures.

Key Facts

Peripheral Nerve Surgery Market Opportunity

Checkpoint Surgical operates in the growing peripheral nerve repair and regeneration market, addressing more than 1 million patients impacted by nerve injuries annually in the United States.

Target Surgical Applications

Nerve Trauma & Reconstruction

• Nerve transection
• Nerve transfer
• Nerve decompression
• Brachial plexus procedures
• Targeted muscle reinnervation (TMR)
• Facial reanimation
• Selective neurectomy for spasticity

Head & Neck Surgery

• Thyroidectomy
• Parotidectomy
• Neck dissection

Orthopedic & Additional Applications

• Revision total joint surgery
• Tendon repair
• Emergency trauma
• Scar barrier applications
• Sleep apnea procedures

Product Portfolio

CHECKPOINT GUARDIAN® Nerve Stimulator

The CHECKPOINT GUARDIAN® is a single-use sterile nerve stimulator intended to provide electrical stimulation of exposed motor nerves or muscle tissue during surgery.

Key Features

• Intraoperative nerve identification
• Nerve protection and preservation
• Diagnostic nerve assessment
• Ability to stimulate through scar tissue
• Muscle contraction modeling
• No return needle required

Surgical Use Cases

• Head & neck surgery
• Peripheral nerve reconstruction
• Plastic surgery
• Orthopedic surgery
• Neurosurgery

CHECKPOINT GEMINI® Bipolar Nerve Stimulator

The CHECKPOINT GEMINI® bipolar stimulation platform is designed for selective nerve stimulation and fascicular-level precision.

Key Features

• Bipolar stimulation probe
• Limited field of charge influence
• Selective neurolysis support
• Intra-fascicular dissection applications
• High-frequency stimulation for fast-twitch muscle activation

CHECKPOINT ACMShield® Soft Tissue Barrier

CHECKPOINT ACMShield® is a dehydrated placental membrane allograft designed for use as a protective barrier during surgical procedures.

Intended Applications

• Soft tissue protection
• Scar barrier applications
• Surgical healing support
• Nerve protection procedures

CHECKPOINT EDGE® Nerve Cutting Kit

The CHECKPOINT EDGE® Nerve Cutting Kit is a sterile, single-use surgical kit intended to aid surgeons in transecting nerve tissue for:

• Nerve graft preparation
• Nerve repair
• Removal of exposed nerve tissue

Key Features

• Circumferential constraint system
• Independent two-handed technique
• Uses standard scalpel blades
• Preserves fascicular group alignment
• Supports consistent aligned coaptation

Nerve Regeneration Platform

Checkpoint Surgical is developing an FDA Breakthrough Device-designated platform for intraoperative nerve regeneration therapy.

Platform Overview

The platform delivers a targeted 10-minute therapeutic electrical stimulation dose designed to promote nerve regeneration during surgery.

Platform Characteristics

• Built on Checkpoint’s established stimulation platform
• Designed for seamless surgical workflow integration
• Two-channel hands-free therapy
• Single-dose per nerve treatment
• Multi-center clinical trials underway
• Category III CPT code pathway established

Clinical Focus

The platform is intended to support improved nerve regeneration and functional recovery following peripheral nerve injury and repair procedures.

Commercial Organization

Checkpoint Surgical operates a hybrid commercial model combining direct sales and distributor partnerships across the United States and international markets.

Commercial Infrastructure

• Nationwide U.S. coverage
• ~300 distributor representatives
• Direct strategic account management
• International distribution across 20 countries
• Specialized peripheral nerve surgery focus

Revenue Channels

Intellectual Property

Checkpoint Surgical maintains a broad intellectual property portfolio supporting its nerve surgery and neurostimulation technologies.

IP Portfolio

• 40+ patents issued and pending
• 30+ international patents
• Design patents and trademarks
• Ongoing next-generation product development
• Protection across major medical device markets

Leadership Team

Derek Lewis — President & Chief Executive Officer

25+ years of experience in medical device product development, operations, and marketing. Joined Checkpoint Surgical in 2018.

Laura Keck — Chief Financial Officer

CPA with 20 years of finance leadership experience in high-growth companies.

Kevin Scanlan — SVP of Clinical Services

Member of the original Checkpoint Surgical launch team with extensive neurostimulation experience.

Elliott Phillips — VP of Sales

25+ years of commercial and medical device sales leadership experience.

Ben Cottrill — VP of Engineering

Medical device product development and engineering leader with prior experience at major medtech companies.

Kristin Wolff — VP of Marketing

Experienced medical device and biologics marketing executive.

Brian Hockett — VP of Operations

Leader in medical device operations, quality, and regulatory systems.

Why Checkpoint Surgical

Specialized Peripheral Nerve Focus

Checkpoint Surgical is focused specifically on peripheral nerve surgery and nerve care technologies.

Established Commercial Platform

The company maintains a scalable commercial infrastructure with national and international reach.

Clinical Adoption

Checkpoint technologies have been used clinically in more than 225,000 procedures.

Strong Intellectual Property Position

The company maintains broad patent protection across multiple nerve care technologies.

Expanding Technology Pipeline

Checkpoint Surgical continues developing next-generation nerve regeneration and repair technologies.

Frequently Asked Questions

What does Checkpoint Surgical specialize in?

Checkpoint Surgical develops medical devices and technologies focused on peripheral nerve surgery, nerve repair, nerve protection, and intraoperative neurostimulation.

Who uses Checkpoint Surgical products?

The company’s products are used by plastic surgeons, hand surgeons, neurosurgeons, orthopedic surgeons, ENT surgeons, and head & neck surgeons.

What is the purpose of intraoperative nerve stimulation?

Intraoperative nerve stimulation helps surgeons identify, assess, preserve, and protect nerves during surgery.

What is the size of the peripheral nerve repair market?

Checkpoint Surgical estimates a total addressable market exceeding $1 billion across current and future nerve care applications.

What differentiates Checkpoint Surgical?

The company combines nerve stimulation technologies, nerve repair tools, biomaterials, and regenerative therapy development within a focused peripheral nerve surgery platform.

Is Checkpoint Surgical developing regenerative technologies?

Yes. The company is developing an FDA Breakthrough Device-designated intraoperative nerve regeneration therapy platform currently being evaluated in clinical trials.